From: MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Variable | 95% CI | ||||
---|---|---|---|---|---|
70-GS Low Risk Patients (n = 215) | p-value | OR | Lower | Upper | |
Age | 0.105 | 0.934 | 0.861 | 1.014 | |
Menopausal Status | Post vs. pre/peri | 0.650 | 0.672 | 0.120 | 3.750 |
Tumor Stage | 2 vs. 1 | 0.155 | 2.504 | 0.706 | 8.880 |
Nodal Status | 1 vs. 0 | 0.003 | 7.957 | 1.884 | 22.512 |
Grade | 2/3 vs. 1 | 0.051 | 5.106 | 0.993 | 26.245 |
70-GS High Risk Patients (n = 135) | p-value | OR | Lower | Upper | |
Age | 0.033 | 1.050 | 1.004 | 1.099 | |
Nodal Status | 1 vs. 0 | 0.048 | 0.121 | 0.015 | 0.978 |
Grade | 2/3 vs. 1 | 0.086 | 0.335 | 0.096 | 1.166 |